Menu
GeneBe

ZHX3

zinc fingers and homeoboxes 3, the group of ZF class homeoboxes and pseudogenes|Zinc fingers C2H2-type

Basic information

Region (hg38): 20:41178447-41317731

Previous symbols: [ "TIX1" ]

Links

ENSG00000174306NCBI:23051OMIM:609598HGNC:15935Uniprot:Q9H4I2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ZHX3 gene.

  • not provided (64 variants)
  • Inborn genetic diseases (39 variants)
  • Coronary artery atherosclerosis (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZHX3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
18
clinvar
6
clinvar
24
missense
59
clinvar
4
clinvar
6
clinvar
69
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
clinvar
2
Total 0 0 59 23 13

Variants in ZHX3

This is a list of pathogenic ClinVar variants found in the ZHX3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
20-41185089-G-A Benign (May 19, 2021)1266725
20-41185209-G-A Likely benign (Jul 15, 2023)3015482
20-41185212-A-G Uncertain significance (Feb 16, 2023)2837788
20-41185218-T-C Likely benign (Sep 03, 2023)3003165
20-41185409-A-AG Benign (May 19, 2021)1285731
20-41202041-C-G Likely benign (Jul 03, 2022)1657327
20-41202065-C-T not specified Uncertain significance (Aug 09, 2021)2364557
20-41202080-C-A not specified Uncertain significance (Jan 23, 2024)3193552
20-41202082-C-T Likely benign (Sep 21, 2023)2798512
20-41202083-G-C not specified Uncertain significance (Dec 20, 2023)3193551
20-41202147-A-T Uncertain significance (Apr 20, 2023)2889849
20-41202162-T-C Uncertain significance (Sep 01, 2022)1402056
20-41202228-T-G not specified Uncertain significance (Dec 20, 2023)3193550
20-41202256-C-T not specified Uncertain significance (Jan 26, 2022)2273736
20-41202259-T-C ZHX3-related disorder Benign (Jan 26, 2024)1641680
20-41202289-G-A Likely benign (Jan 29, 2024)2876617
20-41202359-T-C Uncertain significance (Jun 24, 2023)2995560
20-41202378-G-A not specified Uncertain significance (Jul 07, 2022)2400928
20-41202380-T-A not specified Uncertain significance (Jul 12, 2022)2301107
20-41202381-T-A not specified Uncertain significance (Oct 16, 2023)2069050
20-41202391-A-G Likely benign (Apr 16, 2021)1648036
20-41202394-G-A Likely benign (May 10, 2022)2164969
20-41202411-G-C Uncertain significance (Jan 04, 2023)2804030
20-41202416-T-C not specified Uncertain significance (Jan 04, 2024)3193549
20-41202422-C-T Uncertain significance (Apr 15, 2022)2184795

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ZHX3protein_codingprotein_codingENST00000309060 2139225
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.05080.9491257330131257460.0000517
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.464395340.8230.00002966293
Missense in Polyphen113185.740.608382220
Synonymous0.1682132160.9850.00001261938
Loss of Function3.61829.00.2760.00000164334

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001160.000116
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.0001420.000139
European (Non-Finnish)0.00003530.0000352
Middle Eastern0.000.00
South Asian0.00007210.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Acts as a transcriptional repressor. Involved in the early stages of mesenchymal stem cell (MSC) osteogenic differentiation. Is a regulator of podocyte gene expression during primary glomerula disease. Binds to promoter DNA. {ECO:0000269|PubMed:12659632, ECO:0000269|PubMed:21174497}.;

Recessive Scores

pRec
0.101

Intolerance Scores

loftool
0.291
rvis_EVS
-0.2
rvis_percentile_EVS
39.21

Haploinsufficiency Scores

pHI
0.164
hipred
Y
hipred_score
0.670
ghis
0.530

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.875

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Zhx3
Phenotype
growth/size/body region phenotype; hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;cell differentiation;positive regulation of osteoblast differentiation;negative regulation of transcription, DNA-templated
Cellular component
nucleus;nucleoplasm
Molecular function
RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;transcription corepressor activity;protein binding;protein homodimerization activity;metal ion binding;protein heterodimerization activity